ROCHE'S VERSED AND SCHERING'S DORMALIN JOIN LILLY's CESAMET WITH LATE DECEMBER NDA APPROVALS FROM FDA BUT FACE SCHEDULING DELAY FROM DEA BEFORE MARKETING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".